Significantly, the clinical data revealed that FASN and HMGCR proteins were greatly expressed in advanced PCa patients’ tumor specimens, including CRPC, compared to the normal prostate tissue samples [17,18]. This evidence concerns the gene FASN and posterior cortical atrophy.